NY-MORROW-SODALI
14.1.2020 12:02:06 CET | Business Wire | Press release
Morrow Sodali announced today that Debt Capital Markets industry experts Damian Watkin, Damir Hadžiosmanović, Ken Abela and Tina Siu, have joined the firm as part of a global strategy to strengthen its bonds-related services offering.
The team, which provides 50+ years of combined experience working on over 800 debt-related deals, joins Morrow Sodali from D.F. King and will be based in London and Hong Kong, bolstering the firm’s global presence in Debt Services. They will work alongside leading in-house expert Pia Gowland who from now on will oversee Morrow Sodali’s Debt Services activities in the Americas.
Damian Watkin, who joins Morrow Sodali as a Senior Director in the firm’s London office, brings 20 years’ experience in the capital markets industry working with global financial institutions, corporate and sovereign issuers, with extensive expertise in executing liability management and debt restructuring transactions and researching ownership in capital structures. In his previous role at D.F. King, Mr. Watkin built and led the firm’s bonds business outside of the US market, working with a broad range of debt issuers, and their advisors, in some of the largest or highest profile transactions of recent years.
“We are very excited to join the entrepreneurial and client-focused team at Morrow Sodali and be able to offer a seamless service from a truly global and technology-led execution platform to bond issuers and their advisers,” said Mr. Watkin. “Morrow Sodali now has a global footprint, with experienced execution professionals based in Asia, Europe and the Americas.”
Joining Mr. Watkin in London as a Director, Damir Hadžiosmanović has nearly 20 years’ experience in working with corporate and sovereign issuers, assisting them in executing various liability management transactions and bondholder identifications, as well as debt restructurings and schemes of arrangement.
Ken Abela, who joins Morrow Sodali as a Director, brings nearly 20 years’ experience, of which 17 years in Asia, in assisting corporate and sovereign issuers in executing liability management and debt restructuring transactions. Mr. Abela will be based in Hong Kong and will be responsible for strengthening the firm’s Debt Services offering across Asia Pacific markets.
“We are looking forward to expanding Morrow Sodali’s debt-related services in Asia, providing bond issuers and their advisors in the region with an experienced local point of contact, with the ability to assist with transactions and provide advice to practitioners in their own time zone,” said Mr. Abela.
Joining Mr. Abela in Hong Kong, Tina Siu has assisted in providing D.F. King’s debt-related activities led by Mr. Abela, with a strong track record of supporting bond issuers in executing liability management transactions across Asian markets. Prior to D.F. King, Ms. Siu worked with financial institutions focusing on debt market research as well as conducting financial analysis for corporate clients.
Morrow Sodali Global Corporate Director Giulio Pediconi commented: “We are delighted to welcome such an experienced team within the Morrow Sodali family. With the global expansion of corporate debt markets, our combined expertise across our dedicated hubs in New York, London and Hong Kong will enable us to expand our services and offer our clients a truly global coverage in this key market.”
About Morrow Sodali
Morrow Sodali is a leading provider of strategic advice and shareholder and bondholder services to corporate and sovereign clients around the world. The firm provides corporate boards and executives with strategic advice and services relating to corporate governance, shareholder and bondholder communication and engagement, capital markets intelligence, proxy solicitation, shareholder activism, mergers and acquisitions and debt-related transactions.
From headquarters in New York and London, and offices and partners in major capital markets, Morrow Sodali serves more than 700 corporate clients in 40 countries, including many of the world’s largest multinational corporations. In addition to listed and private companies, its clients include mutual funds, ETFs, stock exchanges and membership associations.
For further information about Morrow Sodali, please visit www.morrowsodali.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20200114005017/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
TVCMALL at MWC 2026: Leading Mobile Accessories Wholesale and Smarter Sourcing1.3.2026 07:00:00 CET | Press release
As MWC Barcelona 2026 highlights the growing role of AI, connectivity, and smarter technology systems, the mobile accessories market is entering a new phase defined by speed and complexity. Product categories continue to expand, designs and styles update faster, and retailers are expected to respond to market changes in shorter cycles. Keeping product lines up to date while managing sourcing efficiently has become a real challenge for retailers and distributors across Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260121405485/en/ TVCMALL at MWC 2026: Leading Mobile Accessories Wholesale and Smarter Sourcing At MWC Barcelona 2026, TVCMALL highlights its role as a leading one-stop mobile accessories wholesaler in Europe, with a clear focus on making wholesale and sourcing easier, faster, and more reliable. With more than 18 years of experience, TVCMALL works closely with 30+ leading retail partners across Europe, supp
Biocytogen Announces Clinical Milestone with First Patient Dosed in Phase 1 Trial of IDEAYA’s First-in-Class B7H3/PTK7 Bispecific TOP1 ADC IDE03428.2.2026 01:00:00 CET | Press release
IDE034 is a B7H3/PTK7 bispecific TOP1 ADC designed to target tumor cells expressing both B7H3 and PTK7 preferentially, and is being evaluated as monotherapy and in combination with IDEAYA’s PARG inhibitor IDE161. IDEAYA has dosed the first patient in its Phase 1 trial of IDE034, initially evaluating safety, tolerability, and PK. First dosing triggers a $5 million milestone payment to Biocytogen under the companies’ option and license agreement. Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that its partner IDEAYA Biosciences, Inc. (“IDEAYA”; Nasdaq: IDYA) has dosed the first patient in IDEAYA’s Phase 1 dose-escalation/expansion clinical trial of IDE034, an investigational B7H3/PTK7 bispecific TOP1 ADC. Pursuant to the companies’ option and license agreement, first patient dosing triggers a $5 million
IQM and Real Asset Acquisition Corp. to Host Conference Call/Webcast to Discuss Proposed Transaction27.2.2026 13:00:00 CET | Press release
IQM Finland Oy, a global leader in full-stack superconducting quantum computers (“IQM”, “IQM Quantum Computers” or the “Company”), and Real Asset Acquisition Corp. (Nasdaq: RAAQ), a special purpose acquisition company (“RAAQ”), announced that they will host a conference call to discuss their recently announced business combination, including certain transaction highlights. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260227472716/en/ IQM Radiance quantum computer As previously disclosed, on February 23, 2026, IQM and RAAQ announced they have entered into a definitive business combination agreement, which will result in IQM becoming a public company and listing American Depositary Shares on one of the two leading U.S. stock exchanges. The transaction provides funding with the aim to accelerate IQM’s technology and commercial development towards fault-tolerance quantum computing, further advancing its position as a leading p
HighRadius Launches $0 Implementation Fee, $0 Subscription Fee via Outcome Based Pricing for oCFO Software27.2.2026 12:00:00 CET | Press release
HighRadius launches Office of the CFO first Outcome Based Pricing with $0 Implementation fee and $0 Subscription until Go-Live. Customers only pay a fraction of realized gains based on P&L impact. Chapter 1: Outcome Based Pricing (OBP)Introduction of OBP: HighRadius, a provider of 190+ AI agents for Order-to-Cash, Accounts Payable, Record-to-Report, and Treasury introduces Outcome Based Pricing (OBP). Three Components of OBP: Customers pay a) $0 in Implementation fees, b) $0 in Subscription fees until Go Live, c) HighRadius earns a fraction of the actual savings realized by the client. Chapter 2: US GAAP & ASC 606 ConstraintsNot Designed for Innovation: The traditional ASC 606 model requires companies to standardize and recognize revenue based on contractual obligations. For a traditional SaaS subscription, the obligation is access to software over time. AI agents are designed to deliver quantifiable, real-time Business Outcomes that do not fit the traditional accounting framework. Cha
Kioxia Appoints Yoshihiko Kawamura as Chief Financial Officer27.2.2026 09:15:00 CET | Press release
Kioxia Holdings Corporation (TOKYO:285A), a world leader in memory solutions, today announced the appointment of Yoshihiko Kawamura as Chief Financial Officer (CFO), effective April 1, 2026. Mr. Kawamura brings extensive international experience to Kioxia, having held assignments at Mitsubishi Corporation’s U.S. headquarters, served as General Manager of its Chicago office, and completed a tenure at the World Bank. At Hitachi, Ltd., he held senior leadership positions, including Chief Strategy Officer (CSO), Chief Financial Officer (CFO), and Chief Risk Management Officer (CRMO), where he was instrumental in leading the company’s management reforms. Since joining Kioxia as Executive Vice President in June 2025, Mr. Kawamura has worked closely with the executive team to advance the business through strategic capital and financial planning. Following its initial public offering on the Prime Market of the Tokyo Stock Exchange in December 2024, Kioxia is entering a new phase of growth char
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom